Pisani Silvia, Evangelista Aleksandra, Chesi Luca, Croce Stefania, Avanzini Maria Antonietta, Dorati Rossella, Genta Ida, Benazzo Marco, Comoli Patrizia, Conti Bice
Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy.
Otorhinolaryngology Unit, Department of Surgical Sciences, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Pharmaceuticals (Basel). 2025 Feb 11;18(2):239. doi: 10.3390/ph18020239.
Mesenchymal stem cells (MSCs) have gained recognition as a highly versatile and promising cell source for repopulating bioengineered scaffolds due to their inherent capacity to differentiate into multiple cell types. However, MSC implantation techniques have often yielded inconsistent clinical results, underscoring the need for advanced approaches to enhance their therapeutic efficacy. Recent developments in three-dimensional (3D) bioengineered scaffolds have provided a significant breakthrough by closely mimicking the in vivo environment, addressing the limitations of traditional two-dimensional (2D) cell cultures. Among these, nanofibrous scaffolds have proven particularly effective, offering an optimal 3D framework, growth-permissive substrates, and the delivery of trophic factors crucial for MSC survival and regeneration. Furthermore, the selection of appropriate biomaterials can amplify the paracrine effects of MSCs, promoting both proliferation and targeted differentiation. The synergistic combination of MSCs with nanofibrous scaffolds has demonstrated remarkable potential in achieving repair, regeneration, and tissue-specific differentiation with enhanced safety and efficacy, paving the way for routine clinical applications. In this review, we examine the most recent studies (2013-2023) that explore the combined use of MSCs and nanofibrous scaffolds for differentiation into cardiogenic, epithelial, myogenic, tendon, and vascular cell lineages. Using PubMed, we identified and analyzed 275 relevant articles based on the search terms "Nanofibers", "Electrospinning", "Mesenchymal stem cells", and "Differentiation". This review highlights the critical advancements in the use of nanofibrous scaffolds as a platform for MSC differentiation and tissue regeneration. By summarizing key findings from the last decade, it provides valuable insights for researchers and clinicians aiming to optimize scaffold design, MSC integration, and translational applications. These insights could significantly influence future research directions and the development of more effective regenerative therapies.
间充质干细胞(MSCs)因其具有分化为多种细胞类型的内在能力,已成为用于重新填充生物工程支架的极具通用性和前景的细胞来源。然而,MSCs植入技术的临床结果往往不一致,这凸显了需要先进方法来提高其治疗效果。三维(3D)生物工程支架的最新进展通过紧密模拟体内环境取得了重大突破,解决了传统二维(2D)细胞培养的局限性。其中,纳米纤维支架已被证明特别有效,它提供了最佳的3D框架、支持生长的底物以及对MSCs存活和再生至关重要的营养因子的递送。此外,选择合适的生物材料可以增强MSCs的旁分泌作用,促进增殖和定向分化。MSCs与纳米纤维支架的协同组合在实现修复、再生和组织特异性分化方面显示出显著潜力,同时提高了安全性和有效性,为常规临床应用铺平了道路。在本综述中,我们研究了最近(2013 - 2023年)探索MSCs与纳米纤维支架联合用于分化为心脏、上皮、肌肉、肌腱和血管细胞谱系的研究。通过PubMed,我们基于搜索词“纳米纤维”、“静电纺丝”、“间充质干细胞”和“分化”识别并分析了275篇相关文章。本综述强调了使用纳米纤维支架作为MSCs分化和组织再生平台的关键进展。通过总结过去十年的关键发现,它为旨在优化支架设计、MSCs整合和转化应用的研究人员和临床医生提供了有价值的见解。这些见解可能会显著影响未来的研究方向和更有效再生疗法的发展。